J2185 MeropenemInjection, meropenem, 100 mg
J2185 payment limit: $0.358 per 100 MG, effective October 1, 2026 through December 31, 2026, based on 2Q26 ASP data. Coinsurance 20%.
70121-1453-07 Meropenem, Amneal Pharmaceuticals, LLC: 100 billing units per package (10 VIAL, GLASS in 1 CARTON / 30 mL in 1 VIAL, GLASS)70121-1454-07 Meropenem, Amneal Pharmaceuticals, LLC: 50 billing units per package (10 VIAL, GLASS in 1 CARTON / 20 mL in 1 VIAL, GLASS)72485-0411-10 Meropenem, Armas Pharmaceuticals Inc.: 50 billing units per package (10 VIAL in 1 CARTON / 20 mL in 1 VIAL)72485-0412-10 Meropenem, Armas Pharmaceuticals Inc.: 100 billing units per package (10 VIAL in 1 CARTON / 20 mL in 1 VIAL)72572-0410-10 Meropenem, Civica, Inc.: 100 billing units per package (10 VIAL in 1 CARTON / 20 mL in 1 VIAL)72572-0412-10 Meropenem, Civica, Inc.: 50 billing units per package (10 VIAL in 1 CARTON / 20 mL in 1 VIAL)72572-0415-10 Meropenem, Civica, Inc.: 50 billing units per package (10 VIAL in 1 CARTON / 20 mL in 1 VIAL)72572-0416-10 Meropenem, Civica, Inc.: 100 billing units per package (10 VIAL in 1 CARTON / 30 mL in 1 VIAL)55150-0207-20 Meropenem, Eugia US LLC: 50 billing units per package (10 VIAL in 1 CARTON / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL)55150-0208-30 Meropenem, Eugia US LLC: 100 billing units per package (10 VIAL in 1 CARTON / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL)63323-0507-20 Meropenem, FreseniUS Kabi USA, LLC: 50 billing units per package (10 VIAL in 1 CARTON / 10 mL in 1 VIAL)63323-0507-21 Meropenem, FreseniUS Kabi USA, LLC: 50 billing units per package (10 VIAL in 1 CARTON / 10 mL in 1 VIAL)63323-0507-25 Meropenem, FreseniUS Kabi USA, LLC: 125 billing units per package (25 VIAL in 1 CARTON / 10 mL in 1 VIAL)63323-0508-25 Meropenem, FreseniUS Kabi USA, LLC: 250 billing units per package (25 VIAL in 1 CARTON / 20 mL in 1 VIAL)63323-0508-30 Meropenem, FreseniUS Kabi USA, LLC: 100 billing units per package (10 VIAL in 1 CARTON / 20 mL in 1 VIAL)63323-0508-31 Meropenem, FreseniUS Kabi USA, LLC: 100 billing units per package (10 VIAL in 1 CARTON / 20 mL in 1 VIAL)00143-9430-10 Meropenem, Hikma Pharmaceuticals USA Inc.: 50 billing units per package (10 VIAL in 1 CARTON / 20 mL in 1 VIAL)00143-9431-10 Meropenem, Hikma Pharmaceuticals USA Inc.: 100 billing units per package (10 VIAL in 1 CARTON / 30 mL in 1 VIAL)00409-0222-10 Meropenem, Pfizer Inc: 50 billing units per package (10 VIAL in 1 CARTON / 10 mL in 1 VIAL)00409-1390-51 Meropenem, Pfizer Inc: 50 billing units per package (10 VIAL in 1 CARTON / 10 mL in 1 VIAL)00409-1391-22 Meropenem, Pfizer Inc: 100 billing units per package (10 VIAL in 1 CARTON / 20 mL in 1 VIAL)00409-3412-10 Meropenem, Pfizer Inc: 100 billing units per package (10 VIAL in 1 CARTON / 20 mL in 1 VIAL)25021-0160-20 Meropenem, Sagent Pharmaceuticals: 50 billing units per package (10 VIAL in 1 CARTON / 20 mL in 1 VIAL)00781-3000-95 Meropenem, Sandoz Inc.: 50 billing units per package (10 VIAL in 1 CARTON / 20 mL in 1 VIAL)00781-3098-95 Meropenem, Sandoz Inc.: 100 billing units per package (10 VIAL in 1 CARTON / 30 mL in 1 VIAL)44567-0145-10 Meropenem, WG Critical Care, LLC: 50 billing units per package (10 VIAL in 1 CARTON / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL)44567-0146-10 Meropenem, WG Critical Care, LLC: 100 billing units per package (10 VIAL in 1 CARTON / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL)44567-0400-10 Meropenem, WG Critical Care, LLC: 50 billing units per package (10 VIAL in 1 CARTON / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL)44567-0401-10 Meropenem, WG Critical Care, LLC: 100 billing units per package (10 VIAL in 1 CARTON / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL)70594-0075-02 Meropenem, Xellia Pharmaceuticals USA, LLC.: 50 billing units per package (10 VIAL, GLASS in 1 CARTON / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS)70594-0076-02 Meropenem, Xellia Pharmaceuticals USA, LLC.: 100 billing units per package (10 VIAL, GLASS in 1 CARTON / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS)Status E: excluded from the PFS by regulation.
J2185 appears in 3 coverage policies from Aetna, Anthem.
| Payer | Policy | Role in policy | Reviewed | Document |
|---|---|---|---|---|
| Aetna | Anthrax (0483) Obiltoxaximab (Anthim), Raxibacumab | covered if criteria are met | Jul 29, 2026 | payer document |
| Aetna | Injectable Medications (0020) | listed, no stance (range J0278-J2543) | Mar 5, 2026 | payer document |
| Anthem | Parenteral Antibiotics for the Treatment of Lyme Disease (CG-MED-98) | not covered | Nov 6, 2025 | payer document |
From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.